Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Jiangsu Jibeier Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.07 Million ≈ $1.62 Million USD) by net assets (CN¥2.37 Billion ≈ $346.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)

Cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688566 share price today for real-time trading data and today's change.

Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu Jibeier Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 688566 stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Tortoise Energy Infrastructure Closed Fund
NYSE:TYG
0.017x
Salfacorp
SN:SALFACORP
0.122x
Shandong Link Science and Technology Co Ltd
SHE:001207
0.031x
Ridgepost Capital, Inc
NYSE:RPC
0.042x
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
0.014x
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
0.054x
Hangzhou Jiebai Group Co Ltd
SHG:600814
0.048x
Hiecise Precision Equipment Co Ltd
SHE:300809
0.040x

Annual Cash Flow Conversion Efficiency for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. Review Jiangsu Jibeier Pharmaceutical Co Ltd (688566) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.45 Billion
≈ $358.46 Million
CN¥248.30 Million
≈ $36.33 Million
0.101x +6.11%
2024-12-31 CN¥2.25 Billion
≈ $329.81 Million
CN¥215.29 Million
≈ $31.50 Million
0.096x +14.41%
2023-12-31 CN¥1.91 Billion
≈ $279.55 Million
CN¥159.50 Million
≈ $23.34 Million
0.083x -6.15%
2022-12-31 CN¥1.69 Billion
≈ $247.93 Million
CN¥150.72 Million
≈ $22.06 Million
0.089x -4.97%
2021-12-31 CN¥1.61 Billion
≈ $235.34 Million
CN¥150.56 Million
≈ $22.03 Million
0.094x +25.73%
2020-12-31 CN¥1.58 Billion
≈ $230.67 Million
CN¥117.36 Million
≈ $17.17 Million
0.074x -69.66%
2019-12-31 CN¥470.46 Million
≈ $68.84 Million
CN¥115.45 Million
≈ $16.89 Million
0.245x -10.41%
2018-12-31 CN¥357.68 Million
≈ $52.34 Million
CN¥97.97 Million
≈ $14.34 Million
0.274x +8.12%
2017-12-31 CN¥440.76 Million
≈ $64.50 Million
CN¥111.66 Million
≈ $16.34 Million
0.253x +134.16%
2016-12-31 CN¥363.15 Million
≈ $53.14 Million
CN¥39.29 Million
≈ $5.75 Million
0.108x --

About Jiangsu Jibeier Pharmaceutical Co Ltd

SHG:688566 China Drug Manufacturers - Specialty & Generic
Market Cap
$757.76 Million
CN¥5.18 Billion CNY
Market Cap Rank
#9817 Global
#2533 in China
Share Price
CN¥25.75
Change (1 day)
-3.59%
52-Week Range
CN¥23.10 - CN¥32.66
All Time High
CN¥51.60
About

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing… Read more